Quick Answer
BioNexus Gene Lab Corp reported Total Revenue of $9.51 million for fiscal year 2024.
BioNexus Gene Lab Corp Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2024 | $9.51M | -2.7% |
| 2023 | $9.77M | -10.6% |
| 2022 | $10.93M | -18.2% |
| 2021 | $13.36M | +17.3% |
| 2020 | $11.39M | +8872.0% |
| 2019 | $127.0K | -40.2% |
| 2018 | $212.3K | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.54M | -3.3% | +12.5% |
| June 30, 2025 | $2.26M | +14.5% | +5.8% |
| March 31, 2025 | $2.14M | -10.3% | -18.8% |
| September 30, 2024 | $2.63M | +3.0% | +33.2% |
| June 30, 2024 | $1.97M | -23.1% | -17.1% |
| March 31, 2024 | $2.38M | +0.2% | -6.7% |
| September 30, 2023 | $2.55M | -0.8% | -0.5% |
| June 30, 2023 | $2.57M | +3.3% | +8.0% |
- BioNexus Gene Lab Corp showed a decrease of -2.7% in Total Revenue compared to the prior fiscal year.
- Over the 2018–2024 period, BioNexus Gene Lab Corp’s total revenue has grown by 4379.2% (from $212.3 thousand to $9.51 million).
- The most recent figure is from BioNexus Gene Lab Corp’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: